Stock 9926 AKESO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Akeso, Inc.

Equities

9926

KYG0146B1032

Delayed Hong Kong S.E.
Other stock markets
 01:58:05 2024-05-22 EDT 		5-day change 1st Jan Change
47.7 HKD +1.06% Intraday chart for Akeso, Inc. -4.02% +2.80%
04-24 Akeso’s Supplemental New Drug Application for Cervical Cancer Drug Accepted by Chinese Regulator MT
04-24 National Medical Products Administration Accepted the Supplemental New Drug Application by Akeso, Inc. for (Cadonilimab, Pd-1/Ctla-4) as First-Line Treatment for Cervical Cancer CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
AKESO, INC. Stock Akeso, Inc.
 5.24B -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 114B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 107B
BIONTECH SE Stock BioNTech SE
 22.22B -
ARGENX SE Stock argenx SE
 21.28B -
BEIGENE, LTD. Stock BeiGene, Ltd.
 17.51B -
  1. Stock Market
  2. Equities
  3. 9926 Stock
  4. Charts Akeso, Inc.
  5. Sector Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW